FDA Inspection 1065487 — Eddy Dagoberto Motta Roldan, M.D.
The FDA completed an inspection of Eddy Dagoberto Motta Roldan, M.D. on Sep 13, 2018 in Antigua Guatemala. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 1 citation was issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 13, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Antigua Guatemala (Guatemala)
Additional Details
Clinical Investigator (CI)
Citations
| ID | CFR | Description |
|---|---|---|
| 7560 | 21 CFR 312.60 | FD-1572, protocol compliance |